NEW YORK (GenomeWeb) – Avant Diagnostics and Amarantus Diagnostics, which are set to merge later this quarter, announced today that they have signed a letter of intent to acquire protein analysis services provider Theranostics Health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.